Please use this identifier to cite or link to this item: https://doi.org/10.1093/medlaw/fws025
Title: Legal and regulatory responses to innovative treatment
Authors: Chan, T.E. 
Keywords: Innovative treatment
Medical negligence
Research regulation
Issue Date: Jun-2013
Citation: Chan, T.E. (2013-06). Legal and regulatory responses to innovative treatment. Medical Law Review 21 (1) : 65-86. ScholarBank@NUS Repository. https://doi.org/10.1093/medlaw/fws025
Abstract: Developments in medical technology, healthcare delivery, and commercial interests in medicine have increased both the potential for conflicts of interest on the part of physicians, and doubts over the sufficiency of patient autonomy as a justification for administering innovative therapy. The legal and regulatory treatment of innovative therapy is therefore an important question, on which there is a current lack of consensus on a number of issues. This paper discusses recent developments in Singapore and uses them as a springboard to flesh out basic regulatory issues that arise from the deployment of innovative treatment: the distinction between innovative treatment and clinical research, the adequacy of the current post hoc scrutiny of innovative therapy under existing legal principles and the need for further specialised regulatory oversight. © The Author [2012]. Published by Oxford University Press; all rights reserved.
Source Title: Medical Law Review
URI: http://scholarbank.nus.edu.sg/handle/10635/113834
ISSN: 09670742
DOI: 10.1093/medlaw/fws025
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

12
checked on Dec 9, 2022

WEB OF SCIENCETM
Citations

14
checked on Dec 9, 2022

Page view(s)

257
checked on Dec 8, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.